Evidence map›Paper›PMID 37868679›Full record

ArticleJournal of community hospital internal medicine perspectives2023

Metaxalone-induced Immune Hemolytic Anemia.

Afoma Onyechi, Jessica Ohemeng-Dapaah, Rushin Patel, Eduzor Onyechi, Mosunmoluwa Oyenuga, Sara Sartaj, Mudresh Mehta, Alexandre Lacasse, Ikechukwu E Anyadibe

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of community hospital internal medicine perspectives, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Afoma OnyechiDepartment of Internal Medicine, SSM St. Mary's Hospital, St. Louis, MO, USA.
Jessica Ohemeng-DapaahDepartment of Internal Medicine, SSM St. Mary's Hospital, St. Louis, MO, USA.
Rushin PatelDepartment of Internal Medicine, SSM St. Mary's Hospital, St. Louis, MO, USA.
Eduzor OnyechiDepartment of Emergency Medicine, General Western Hospital, Swindon, United Kingdom.
Mosunmoluwa OyenugaDepartment of Internal Medicine, Abbott Northwestern Hospital, Minneapolis, MN, USA.
Sara SartajDepartment of Internal Medicine, SSM St. Mary's Hospital, St. Louis, MO, USA.
Mudresh MehtaDivision of Hematology/Oncology, SSM St. Mary's Hospital, St. Louis, MO, USA.
Alexandre LacasseDepartment of Internal Medicine, SSM St. Mary's Hospital, St. Louis, MO, USA.
Ikechukwu E AnyadibeDepartment of Emergency Medicine, General Western Hospital, Swindon, United Kingdom.
St. Mary's Hospital · USSt. Mary's Medical Center · USAbbott Northwestern Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced immune hemolytic anemia (DIIHA) is a relatively uncommon cause of anemia, and its diagnosis can be challenging. Although beta-lactam antimicrobial agents are often associated with DIIHA, any medication can potentially cause it. We describe a patient presenting with yellow skin discoloration and orange-colored urine after starting metaxalone for treatment of lumbosacral sprain. Laboratory studies were consistent with warm hemolytic anemia. Symptoms improved remarkably after discontinuation of metaxalone, coupled with initiation of glucocorticoids and rituximab.

Indexed as

Drug induced immune hemolytic anemiaHemolysisMetaxalone

Identifiers

PMID37868679
PMCPMC10589045
OpenAlexW4386400035

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.